HomeComparePLD vs HOLX

PLD vs HOLX: Dividend Comparison 2026

PLD yields 3.18% · HOLX yields 2.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.48M in total portfolio value
10 years
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →

Portfolio growth — PLD vs HOLX

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPLDHOLX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PLD + HOLX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PLD pays
HOLX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
At 15% tax rate, PLD beats the other by $4,467,703.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PLD + HOLX for your $10,000?

PLD: 50%HOLX: 50%
100% HOLX50/50100% PLD
Portfolio after 10yr
$3.26M
Annual income
$2,628,375.10/yr
Blended yield
80.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PLD buys
13
HOLX buys
0
PoliticianChamberTickerTypeAmountDate
David Taylor🏢 House$PLD▼ Sell$1,001 - $15,0002026-02-26
David Taylor🏢 House$PLD▲ Buy$1,001 - $15,0002026-01-29
David Taylor🏢 House$PLD▼ Sell$1,001 - $15,0002026-01-16
Ro Khanna🏢 House$PLD▲ Buy$1,001 - $15,0002025-08-26
Dan Newhouse🏢 House$PLD▲ Buy$1,001 - $15,0002025-08-18
David Taylor🏢 House$PLD▲ Buy$1,001 - $15,0002025-08-14
David Taylor🏢 House$PLD▲ Buy$1,001 - $15,0002025-08-07
Shelley Moore Capito🏛 Senate$PLD▲ Buy$1,001 - $15,0002025-08-01
Shelley Moore Capito🏛 Senate$PLD▲ Buy$1,001 - $15,0002025-08-01
Thomas H. Kean🏢 House$PLD▲ Buy$1,001 - $15,0002025-06-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPLDHOLX
Forward yield3.18%2.65%
Annual dividend / share$4.10$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR74.4%0%
Portfolio after 10y$6.50M$23.6K
Annual income after 10y$5,256,436.18$314.03
Total dividends collected$6.37M$2.9K
Payment frequencyquarterlyquarterly
SectorREITHealthcare
Analyst consensusBuyHold
Analyst price target$136.00$77.80

Year-by-year: PLD vs HOLX ($10,000, DRIP)

YearPLD PortfolioPLD Income/yrHOLX PortfolioHOLX Income/yrGap
1← crossover$11,255$555.24$10,965$264.73+$290.00PLD
2$13,062$1,018.59$12,004$271.27+$1.1KPLD
3$15,903$1,926.67$13,121$277.55+$2.8KPLD
4$20,839$3,823.32$14,323$283.54+$6.5KPLD
5$30,464$8,166.08$15,615$289.27+$14.8KPLD
6$52,054$19,457.30$17,003$294.73+$35.1KPLD
7$109,886$54,188.93$18,493$299.93+$91.4KPLD
8$304,030$186,451.18$20,093$304.87+$283.9KPLD
9$1,166,125$840,813.32$21,809$309.57+$1.14MPLD
10$6,504,190$5,256,436.18$23,649$314.03+$6.48MPLD

PLD vs HOLX: Complete Analysis 2026

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →
📬

Get this PLD vs HOLX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PLD vs SCHDPLD vs JEPIPLD vs OPLD vs KOPLD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.